BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 33557670)

  • 1. T-box transcription factor TBX1, targeted by microRNA-6727-5p, inhibits cell growth and enhances cisplatin chemosensitivity of cervical cancer cells through AKT and MAPK pathways.
    Liu H; Song M; Sun X; Zhang X; Miao H; Wang Y
    Bioengineered; 2021 Dec; 12(1):565-577. PubMed ID: 33557670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-34b-3p-mediated regulation of STC2 and FN1 enhances chemosensitivity and inhibits proliferation in cervical cancer.
    Jin S; Wang W; Xu X; Yu Z; Feng Z; Xie J; Lv H
    Acta Biochim Biophys Sin (Shanghai); 2024 May; 56(5):740-752. PubMed ID: 38477044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-7-5p Promotes Cisplatin Resistance of Cervical Cancer Cells and Modulation of Cellular Energy Homeostasis by Regulating the Expression of the PARP-1 and BCL2 Genes.
    Yang F; Guo L; Cao Y; Li S; Li J; Liu M
    Med Sci Monit; 2018 Sep; 24():6506-6516. PubMed ID: 30219819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of long noncoding RNA NCK1-AS1 increases chemosensitivity to cisplatin in cervical cancer.
    Zhang WY; Liu YJ; He Y; Chen P
    J Cell Physiol; 2019 Apr; 234(4):4302-4313. PubMed ID: 30221354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated microRNA-130b-5p or silenced ELK1 inhibits self-renewal ability, proliferation, migration, and invasion abilities, and promotes apoptosis of cervical cancer stem cells.
    Huang Y; Luo F
    IUBMB Life; 2021 Jan; 73(1):118-129. PubMed ID: 33295145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of miR-202-5p silencing PIK3CA gene expression on proliferation, invasion, and epithelial-mesenchymal transition of cervical cancer SiHa cells through inhibiting PI3K/Akt/mTOR signaling pathway activation.
    Zheng Y; Xie L; Xu S; Yan W; Zhang H; Meng Y; Liu J; Wei X
    Mol Cell Biochem; 2021 Nov; 476(11):4031-4044. PubMed ID: 34244973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long Noncoding RNA GAS5, Which Acts as a Tumor Suppressor via microRNA 21, Regulates Cisplatin Resistance Expression in Cervical Cancer.
    Wen Q; Liu Y; Lyu H; Xu X; Wu Q; Liu N; Yin Q; Li J; Sheng X
    Int J Gynecol Cancer; 2017 Jul; 27(6):1096-1108. PubMed ID: 28472815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TBX1 Functions as a Tumor Suppressor in Thyroid Cancer Through Inhibiting the Activities of the PI3K/AKT and MAPK/ERK Pathways.
    Wang N; Li Y; Wei J; Pu J; Liu R; Yang Q; Guan H; Shi B; Hou P; Ji M
    Thyroid; 2019 Mar; 29(3):378-394. PubMed ID: 30543152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA LINC00460 promotes proliferation and inhibits apoptosis of cervical cancer cells by targeting microRNA-503-5p.
    Lin L; Xin B; Jiang T; Wang XL; Yang H; Shi TM
    Mol Cell Biochem; 2020 Dec; 475(1-2):1-13. PubMed ID: 32740791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long Noncoding RNA Brain Cytoplasmic RNA 1 Induces Cisplatin-Resistance of Cervical Cancer Cells by Sponging MicroRNA-330-5p and Upregulating High-Mobility Group Box 3.
    Sun D; Cao R; Han L; Yu X; Wang H; Wang X; Chen X
    Gynecol Obstet Invest; 2022; 87(3-4):200-210. PubMed ID: 35705019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-505-5p functions as a tumor suppressor by targeting cyclin-dependent kinase 5 in cervical cancer.
    Kapora E; Feng S; Liu W; Sakhautdinova I; Gao B; Tan W
    Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31266812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long noncoding RNA LEF1-AS1 acts as a microRNA-10a-5p regulator to enhance MSI1 expression and promote chemoresistance in hepatocellular carcinoma cells through activating AKT signaling pathway.
    Gao J; Dai C; Yu X; Yin XB; Zhou F
    J Cell Biochem; 2021 Jan; 122(1):86-99. PubMed ID: 32786108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LINC00673 exerts oncogenic function in cervical cancer by negatively regulating miR-126-5p expression and activates PTEN/PI3K/AKT signaling pathway.
    Shi WJ; Liu H; Ge YF; Wu D; Tan YJ; Shen YC; Wang H; Xu H
    Cytokine; 2020 Dec; 136():155286. PubMed ID: 32950808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-520d-5p functions as a tumor-suppressor gene in cervical cancer through targeting PTK2.
    Zhang L; Liu F; Fu Y; Chen X; Zhang D
    Life Sci; 2020 Aug; 254():117558. PubMed ID: 32198053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PSAT1 Upregulation Contributes to Cell Growth and Cisplatin Resistance in Cervical Cancer Cells via Regulating PI3K/AKT Signaling Pathway.
    Duan W; Liu X
    Ann Clin Lab Sci; 2020 Jul; 50(4):512-518. PubMed ID: 32826249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum miR-486-5p as a diagnostic marker in cervical cancer: with investigation of potential mechanisms.
    Li C; Zheng X; Li W; Bai F; Lyu J; Meng QH
    BMC Cancer; 2018 Jan; 18(1):61. PubMed ID: 29316891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long noncoding RNA LINC00173 is downregulated in cervical cancer and inhibits cell proliferation and invasion by modulating the miR-182-5p/FBXW7 axis.
    Zhang J; Zhou M; Zhao X; Wang G; Li J
    Pathol Res Pract; 2020 Aug; 216(8):152994. PubMed ID: 32402537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-140-5p targets insulin like growth factor 2 mRNA binding protein 1 (IGF2BP1) to suppress cervical cancer growth and metastasis.
    Su Y; Xiong J; Hu J; Wei X; Zhang X; Rao L
    Oncotarget; 2016 Oct; 7(42):68397-68411. PubMed ID: 27588393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-181a enhances the chemoresistance of human cervical squamous cell carcinoma to cisplatin by targeting PRKCD.
    Chen Y; Ke G; Han D; Liang S; Yang G; Wu X
    Exp Cell Res; 2014 Jan; 320(1):12-20. PubMed ID: 24183997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-497 accelerates apoptosis while inhibiting proliferation, migration, and invasion through negative regulation of the MAPK/ERK signaling pathway via RAF-1.
    Tao L; Zhang CY; Guo L; Li X; Han NN; Zhou Q; Liu ZL
    J Cell Physiol; 2018 Oct; 233(10):6578-6588. PubMed ID: 29150931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.